2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$2.96-$0.04 (-1.50%)
Price as of Nov 13, 2026 2:03 PM EST- $130.7MMarket Cap
- 88.68%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$2.96-$0.04 (-1.50%)
LUNG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.00 | ||
Change | +$0.02 (+0.67%) | ||
Open | $2.95 | ||
High | $3.17 | ||
Low | $2.88 | ||
Previous Close | $2.98 | ||
Volume | 1,089,463 | ||
30-Day Average Volume | 1,164,677 | ||
1-Week Change | 17.19% | ||
1-Month Change | 66.67% | ||
1-Year Change | 88.68% | ||
3-Year Change | -67.57% | ||
5-Year Change | -92.54% | ||
Fundamentals | |||
Shares Outstanding | 43.6M | ||
Total Assets | $110.2M | ||
Market Cap | $130.7M | ||
Enterprise Value | $115.8M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$8.4M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$8.0M | ||
EBITDA | -$7.8M | ||
Net Working Capital | $63.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 4 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue